Compounds > pivalylbenzhydrazine
Page last updated: 2024-12-05

pivalylbenzhydrazine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

pivalylbenzhydrazine: RN given refers to parent cpd; structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID9375
CHEMBL ID2106941
CHEBI ID134868
SCHEMBL ID149084
SCHEMBL ID20394102
MeSH IDM0053209

Synonyms (42)

Synonym
CBDIVE_000207
n-benzyl pivalhydrazide
betamezide
pivhydrazine [ban]
pivazid
pivalyl benzylhydrazine
pivalic acid, 2-benzylhydrazide
pivaloylbenzylhydrazine
n'-benzylpivalohydrazide
brn 0744565
ro 4-1634
2,2-dimethylpropanoic acid 2-(phenylmethyl)hydrazide
tersavide
pivolinsaeure-n'-benzylhydrazid
2'-benzylpivalohydrazide
tersavid
pivalylbenzhydrazine
propanoic acid, 2,2-dimethyl-, 2-(phenylmethyl)hyrazide
einecs 206-180-9
pivhydrazine
betamezid
CHEBI:134868
n'-benzyl-2,2-dimethylpropanehydrazide
tk1t520asg ,
unii-tk1t520asg
306-19-4
CHEMBL2106941
AKOS016033535
FWWDFDMCZLOXQI-UHFFFAOYSA-N
SCHEMBL149084
pivalylbenzhydrazine [mi]
1-pivaloyl-2-benzyl-hydrazin
SCHEMBL20394102
pivazide
DB09252
DTXSID50184667
SR-01000883696-1
sr-01000883696
Q7199626
CS-0613908
HY-148158
EN300-9546535
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
benzenesAny benzenoid aromatic compound consisting of the benzene skeleton and its substituted derivatives.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (16)

TimeframeStudies, This Drug (%)All Drugs %
pre-199016 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 11.56

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index11.56 (24.57)
Research Supply Index2.89 (2.92)
Research Growth Index4.45 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (11.56)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other17 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
SubstanceRelationship StrengthStudiesTrialsClassesRoles
iproniazid
[no description available]		2.6330carbohydrazide;
pyridines
hydrazine
diamine : Any polyamine that contains two amino groups.		3.64100azane;
hydrazines		EC 4.3.1.10 (serine-sulfate ammonia-lyase) inhibitor
prenylamine
Prenylamine: A drug formerly used in the treatment of angina pectoris but superseded by less hazardous drugs. Prenylamine depletes myocardial catecholamine stores and has some calcium channel blocking activity. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1406)		1.9310diarylmethane
benzylhydrazine
benzylhydrazine: RN given refers to parent cpd		1.9310
ConditionIndicatedRelationship StrengthStudiesTrials
Angor Pectoris
[description not available]		03.95140
Angina Pectoris
The symptom of paroxysmal pain consequent to MYOCARDIAL ISCHEMIA usually of distinctive character, location and radiation. It is thought to be provoked by a transient stressful situation during which the oxygen requirements of the MYOCARDIUM exceed that supplied by the CORONARY CIRCULATION.		03.95140
Heart Valve Diseases
Pathological conditions involving any of the various HEART VALVES and the associated structures (PAPILLARY MUSCLES and CHORDAE TENDINEAE).		01.9310
Blood Pressure, High
[description not available]		01.9310
Hypertension
Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more.		01.9310
Arteriosclerosis, Coronary
[description not available]		01.9310
Coronary Heart Disease
[description not available]		01.9310
Coronary Artery Disease
Pathological processes of CORONARY ARTERIES that may derive from a congenital abnormality, atherosclerotic, or non-atherosclerotic cause.		01.9310
Coronary Disease
An imbalance between myocardial functional requirements and the capacity of the CORONARY VESSELS to supply sufficient blood flow. It is a form of MYOCARDIAL ISCHEMIA (insufficient blood supply to the heart muscle) caused by a decreased capacity of the coronary vessels.		01.9310